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A novel phantom design for brachytherapy quality 
assurance 
INTRODUCTION 
In	 brachytherapy,	 radioactive	 sources	 are	
placed	near	or	within	the	tumor	volume	in	order	
to	maximize	the	dose	delivery	to	the	tumor	and	
minimize	 the	 dose	 to	 the	 surrounding	 normal	
tissues.	 GYN	 brachytherapy	 treatments	 for																									
cervix,	 vaginal	 and	 endometrial	 cancers	 have	
been	 commonly	 used	 for	 several	 decades	 (1).																				
Accuracy	 of	 dose	 calculation	 by	 the	 treatment	
planning	 systems	 plays	 a	 vital	 role	 on	 the																											
success	 of	 these	 brachytherapy	 treatments.	 As	
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ABSTRACT 
Background: One major challenge in brachytherapy is to verify the accuracy of 
dose distribuons calculated by the treatment planning system. In this 
project, a new phantom design has been introduced for quality assurance of 
dose distribuons in gynocological (GYN) brachytherapy implants using EBT 
GafChromic film. Materials and Methods: This phantom has been designed 
and fabricated from 90 slabs of 18×16×0.2 cm
3
 Perspex to accommodate a 
tandem and ovoids assembly, which is normally used for GYN brachytherapy 
treatment. In addion, this phantom design is allowing the use EBT 
GafChromic films for dosimetric verificaon of GYN implants with Cs-137 
Selectron LDR system. With this assembly, GafChromic films were exposed 
using a plan designed to deliver 2.5 Gy dose to point "A" in Manchester 
system for tandem and ovoids configuraons and to deliver 1.5 Gy of dose to 
0.5 cm distance from the lateral surface of ovoids for using ovoid-pair. The 
measured dose distribuons with GafChromic films were compared with the 
TPS isodose lines both numerically and spaally. For a quantave analysis of 
the results, the measured doses values at several points of interest were 
evaluated with the treatment planning data and values obtained following the 
TG-43 dose calculaon formalism. Results: The results of these invesgaons 
have indicated that the new phantom design enables us to measure 
differences of greater than ±6% for LDR brachytherapy GYN treatments. 
Conclusion: The new phantom design could be ulized for the QA procedure 
of the brachytherapy remote aCer loading systems to confirm the accuracy of 
dose distribuon in GYN implants. 
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brachytherapy	 techniques	 become	 more																									
complex,	 the	quality	assurance	(QA)	 techniques	
have	 to	 be	 modi%ied	 to	 provide	 a	 sound	 and	
practical	 method	 of	 veri%ication	 of	 treatment												
delivery	system.		The	progress	is	needed	for	QA	
of	complex	brachytherapy	treatment	techniques,	
particularly	 when	 it	 involves	 treatment	 with	
complex	 low	dose	 rate	 (LDR)	or	high	dose	 rate	
(HDR)	gynecologic	(GYN)	systems.		The	QA	tests	
are	 required	 when	 a	 new	 planning	 system	 has	
been	 introduced	 for	 clinical	 application.	 	 For																			
example,	 recently	 a	 new	 high	 dose	 rate																				
brachytherapy	 system	 has	 been	 introduced	
based	 on	 60Co	 radionuclide	 (GZP6	 machine)	(2).	
This	system	has	its	own	planning	system	which	
may	require	QA	tests	before	it	is	implemented	in	
clinical	procedures.	
Experimental	 veri%ication	 of	 the	 dose																								
accuracy	 is	 one	 possible	 QA	 procedures	 for																							
determination	 of	 any	 over-dose	 or	 under-dose	
area	in	the	brachytherapy	planning	volume.		One	
important	criteria	for	these	experimental	setups	
is	to	have	a	2D	or	3D	dosimeter	with	high	spatial	
resolution	such	as	GafChromicTM	(also	known	as	
RadiochromicTM:	 previously	 distributed	 by																					
International	 Speciality	 Product	 (ISP)	 but	 it	 is	
presently	 distributed	 by	 the	 Ashland	 Re%ining	
Company)	 %ilms.	 Different	 investigators	 had	
demonstrated	 the	 usefulness	 of	 the	 EBT																													
GafChromicTM	 %ilms	 for	 brachytherapy	 source	
dosimetry	 (3,4).	 These	 %ilms	 can	 be	 cut	 to	 the	
shape	of	the	experimental	geometry	for	the	best	
representation	of	the	dosimetric	setup.		 
In	 this	 project,	 a	 new	 phantom	 has	 been																			
designed	 and	 fabricated	 for	 dosimetric																												
veri%ication	 of	 the	GYN	 implants	with	 low	dose	
rate	 (LDR)	 or	 high	 dose	 rate	 (HDR)	 systems,												
using	EBT	GafChromicTM	 %ilm.	The	accuracy	and	
functionality	 of	 this	 phantom	 design	 has	 been	
examined	 using	 a	 well	 stablished	 LDR	 137Cs																						
Selectron	 remote	 afterloading	 system,	which	 is	
distributed	 by	 Nucletron	 (Nucletron	 BV,																	
Veenendaal,	The	Netherlands)	(5).		
This	phantom	design	 enable	us	 to	 verify	 the	
accuracy	 of	 the	 dose	 distributions	 around																											
various	 combinations	 of	 tandem	 and	 ovoid																							
applicators.	 The	 results	 of	 the	 measured	 data	
with	this	device	were	compared	with	calculated	
values	 from	 treatment	 planning	 systems	 and	
also with	 hand	 calculations	 based	 on	 TG-43																			
formalism.		
	
	
MATERIALS	AND	METHODS	
	
LDR	 Cs-137	 selectron	 remote	 after-loading																									
system	
In	the	present	study,	 the	reference	points	 for	
dose	 prescription	 were	 selected	 based	 on						
Manchester	 system	 (6)	 and	 ICRU38																																									
recommendation	 (7).	 A	 tandem	 and	 ovoids																						
combination	 was	 selected,	 with	 5	 cm	 long	 on	
tandem	 #1	 and	 large	 size	 ovoids																																						
(3cm	diameter).	With	 this	 assembly	 a	 set	 of	 17	
active	 and	dummy	pellets	were	used	 in	 tandem	
and	8	pellets	 in	 each	ovoid.	 From	 the	pellets	 in	
tandem,	 numbers	 1,4,7,8,9,10,11,12,13	 were	
chosen	 to	 be	 active.	 In	 each	 ovoid,	 pellets																						
numbers	 2	 to	 7	 were	 considered	 active.	 The																			
remainder	 pellets	 were	 non-active,	 in	 order	 to	
deliver	2.5	Gy	of	dose	to	point	"A" in	Manchester	
system	 (6)	 in	 1.08	 hours.	 For	 using	 ovoid-	 pair	
geometry,	 large	 size	 (3	 cm	 diameter)	 ovoids	
were	selected.	Again,	pellet	numbers	2	to	7	were	
considered	 active	 and	 the	 remainders	 were																					
non-active	 to	 deliver	 1.5	 Gy	 of	 dose	 to	 0.5	 cm		
lateral	 distance	 from	 surface	 of	 ovoids	 in	 1.01	
hours.	 This	 dose	 represents	 the	 same	 dwell																					
positions	and	dwell	times	as	the	ovoid	portion	of	
the	tandem	and	ovoids	assembly.	The	Nucletron	
(PLATO	v.11.4)	treatment	planning	system	(TPS)	
was	 utilized	 for	 calculation	 of	 the	 dose	
distribution	by	this	system	(5).		
	
New	phantom	design	and	dose	measurements	
technique	
The	 new	 phantom	 has	 been	 designed	 and													
fabricated	 from	 90	 slabs	 of	 18×16×0.2	 cm3																				
Perspex	 to	 accommodate	 GYN	 applicators	
(tandem	 and	 ovoid).	 This	 con%iguration	 enables	
us	 to	 verify	 the	 dose	 distributions	 around	 the	
applicator	with	high	spatial	resolution.		Figure	1	
shows	 the	 schematic	 diagram	 of	 this	 phantom	
from	 different	 perspective	 views	 and	 also	 the	
picture	of	the	sample	applicator	assembly	placed	
in	the	phantom.	
The	 thin	 layers	 of	 the	 slabs	 were	 carefully																								
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machined	 to	 accommodate	 the	 GafChromicTM	
%ilms	 in	 between	 the	 slabs	 for	 radiation																															
dosimetry.	 Also,	 the	 phantom	 design	 could	 be	
adjusted	 with	 some	 adaptive	 inserts	 to																														
accommodate	other	ovoid	sizes.				
The	points	of	interests	include	points	"A" and	
"B" in	 Manchester	 system	 for	 tandem	 and	
ovoids	 combination	and	points	"D" and	"F" for																										
ovoid-pair,	 as	 shown	 in	 %igure	 2,	 which	 	 are																							
located	at	0.5	cm	and	1.0	cm	distances	from	the	
lateral	 surface	 of	 ovoid,	 respectively.	 Also,	 the	
measured	isodose	lines	were	compared	with	the	
treatment	 planning	 data.	 Figure	 3	 shows	 the																
picture	 of	 the	 irradiated	 %ilms	 that	were	 cut	 in	
various	sizes	and	shape	 to	match	 the	curvature	
and	location	of	the	applicator.				
 
Film dosimetry procedure 
For	 a	 qualitative	 evaluation	 of	 the	 new																				
phantom	design,	several	 layers	of	GafChromicTM	
%ilm	have	been	irradiated	using	the	tandem	and	
ovoid	 combination	 and	 ovoid-pair	 geometry.	
The	 irradiated	 %ilms	 for	 any	 implant	 geometry	
and	 calibration	 procedures	 were	 scanned	 with	
the	 same	 technique	 after	 24	 hours	 from																										
exposure	 time.	As	suggested	 in	 the	guideline	of	
the	GafChromicTM	 %ilms,	 the	 irradiated	 %ilms	 for	
Figure 1. Schemac diagrams of the new phantom design 
with the lateral view of the GYN applicator (A), Axial View 
(B), a photograph of the GYN tandem and ovoid applicator 
placed within the phantom ©, and  schemacs of different 
layers of the phantom and applicator (D).  (A patent for this 
phantom design has been submiFed to the office of                    
Industrial property with registraon number of 73752). 
Figure 2. Schemac diagram of the tandem-ovoids and  
ovoid-pair applicators and calculated points relave to the 
applicators (Graphs are not to the scale). 
Figure 3. Different slices of EBT-1 films, exposed to the           
radiaon from tandem and ovoid Assembly.  These films 
were cut in different size and shape to match the curvature 
of the applicators and were placed various locaons in the 
phantom. The labels on the films are used to idenfy the 
orientaon and posion of the films within the phantom. 
(Z=0 represents a surface that transverse axes of film are on 
ovoids center).  
both	calibration	and	measurement	process	were	
scanned in	the	landscape	orientation	(8).		
Scanned	 EBT	 GafChromicTM	 %ilms	 were																								
transformed	 to	 IMAGEJ	 software																																											
(Java-based	image	processing	program,	National	
Institute	 of	 Health)	 (9).	 The	 dose	 value	 of																								
reference	 point	 according	 to	 its	 position	 in	 the	
%ilm	 was	 calculated.	 Both	 the	 calibrated	 and																					
experimental	 %ilm	 scanning	 have	 been																																	
performed	 using	 100	 dpi	 resolutions.	 The	 pixel	
value	was	 obtained	 from	 IMAGEJ	 software.	 The	
maximum	 possible	 reading	 of	 the	 scanner	 was	
I0=65535.																																																														
Net	 optical	 density	 (NOD)	 is	 obtained	 by																							
subtracting	 the	 reading	 for	 the	 base	 fog	 (OD	 of	
un-irradiated	 %ilm)	 form	 the	 measured	 optical	
density	(10).																																																		
Int. J. Radiat. Res., Vol. 14 No. 1, January 2016 69 
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TG-43	calculation	
For	LDR	137	Cs	Selectron	remote	after	loading	
unit	 %ilm	 dosimetries	 with	 the	 new	 phantom	
have	been	completed	at	multiple	 levels	 relative	
to	the	GYN	applicators.	TG-43	calculations	were	
considered	for	some	interesting	points	to	verify	
the	 agreement	 between	 calculated	 dose	 value	
from	%ilm	dose	measurements	and	dose	value	in	
treatment	planning.		
	TG-43	 formalism	 was	 employed	 depend	 on	
dosimetric	 parameters	 of	 137Cs	 source.	 These	
parameters	 consist	 of	 air	 kerma	 strength,	 dose	
rate	 constant,	 geometry	 function,	 radial	 dose	
function	 and	 anisotropy	 function.	 	 TG-43										
parameters	 of	 137Cs	 Selectron	 LDR	 brachy-
therapy	 sources	 were	 considered	 from	 Sina's	
Monte	Carlo	simulation	 (11).	Dose	rate	 	constant	
value	for	this	unit	was	1.102	(cGyh-1U-1).		
	
Uncertainty	analysis	
The	 accurate	 results	 of	 GafChoromicTM	 %ilm	
dosimetry	 signi%icantly	 depend	 on	 the	 position	
accuracy	of	the	source	with	respect	to	the	point	
of	 interest	 (12).	 A	 special	 attention	 was	 paid	 to	
the	 distances	 between	 the	 phantom’s	 edge	 and	
edge	of	the	applicator	and	the	%ilm.	
	The	 distance	 between	 the	 phantom	 slabs’	
edge	 and	 the	 applicators	 is	 95	 micrometer.	
Moreover,	 there	 is	a	0.1	mm	gap	between	edge	
of	 the	 machined	 %ilm	 and	 the	 phantom’s	 edge.	
Also,	 there	 is	 a	 0.5	 millimeter	 error	 in																																
determining	the	position	of	points	of	interest.	
With	considering	the	slope	of	dose	pro%ile	at	
level	of	point	"A" from	IMAGEJ	software,	we	can	
estimate	the	uncertainty	of	total	dose	due	to	the	
uncertainty	 of	 the	 coordinate	 of	 the	 points	 of	
interests.	
RESULTS 
 
EBT	GafChromic	(ilm	calibration	
The	 calibration	 curve	 of	 the	 EBT																																				
GafChromicTM	 %ilm	 response	 has	 ±5%																																		
uncertainty.	 Moreover,	 a	 2	 %	 of	 uncertainty	 is	
attributed	due	to	the	energy	difference	between	
60Co	 (used	 for	 calibration)	 and	 137Cs.	 The																												
uncertainty	 of	 source-to-%ilm	 positioning	 is	
4.25%.	Table	1	shows	the	uncertainties	analysis	
for	dose	measurements	in	this	study.		
	
Results	 of	 selectron	 	 LDR	 brachytherapy																	
measurements	
The	 value	 of	 reference	 air	 kerma	 rate	 for																							
TG-43	 dose	 calculation	 is	 extracted	 from																									
treatment	 planning	 system	 which	 was																										
87.88×10-6	Gym2h-1.	The	quantitative	analysis	of	
the	 measured	 data	 for	 Selectron	 137Cs	 LDR	
source	 and	 TG-43	 dose	 calculation	 is	 shown	 in	
table	 2.	 These	 results	 show	 a	 good	 agreement	
(about	 6%)	 between	 the	 %ilm	 dose	
measurements,	 TG-43	 dose	 calculation	 and	
treatment	planning	using	designed	phantom.			
Table 1. Total uncertainty analysis for film dose                        
measurements.  
Source of uncertainty 
Percent of 
uncertainty 
Source-to-film posioning (Δa) 4.25% 
Calibraon curve fit (Δb) 5% 
Difference between film calibraon source 
And Brachytherapy source (Δc) 2%  
       Total uncertainty (                               ) 6.86% 
70 Int. J. Radiat. Res., Vol. 14 No. 1, January 2016 
Table  2. Comparison between the measured and calculated dose values at different points around a typical applicators in GYN 
implant of Selectron 
137
Cs LDR source. 
Points 
Dose-
treatment  
planning 
(cGy) 
Dose-TG-
43 (cGy) 
Dose- Film 
(cGy) 
Difference                      
between                         
planning and            
TG-43                             
calcula#on (%) 
Difference                      
between film      
dosimetry and            
TG-43                            
calcula#on (%) 
Difference                       
between film          
dosimetry and                                                    
treatment                      
planning (%) 
Point A 250.0 255.4 244.0 -2.1% -4.4% -2.4% 
Point B 70.0 71.1 67.0 -1.5% -5.7% -4.3% 
Point D 150.0 153.2 145.8 -2.0% -4.8% -2.8% 
Point F 100.0 102.0 95.8 -1.9% -6.0% -4.2% 
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DISCUSSION	AND	CONCLUSION	
	
A	sophisticated	device	 for	 veri%ication	of	 the	
accuracy	of	dose	distribution	by	a	3D	treatment	
delivery	 system	 in	 brachytherapy	 is	 greatly																							
desirable.	 	 In	this	project,	a	novel	phantom	was	
designed	 and	 fabricated	 for	 QA	 of	 the	 dose																					
distributions	 around	 GYN	 brachytherapy																							
treatments,	 using	 EBT	 GafChromicTM	 %ilm.	 The	
accuracy	of	this	device	has	been	examined	with	
LDR	 selectron	 remote	 afterloading	 system	with	
137Cs	 sources.	 The	 result	 of	 using	 this	 phantom	
for	 Selectron	 system	 shows	 good	 agreement										
between	 the	 %ilm-measured	 dose	 values,	 TG-43	
based	 calculated	 data	 and	 treatment	 planning	
values	 (about	 6%).	 Since	 the	 accuracy	 of	 the	
measurements	 was	 checked	 at	 some	 reference	
points	and	also	 for	 isodose	 lines,	 it	 is	predicted	
to	obtain	good	results	for	other	points	as	well.	In	
table	2,		despite	the	fact	that	same	formalism	has	
been	 used	 for	 the	 hand	 calculation	with	 TG-43	
and	 treatment	 planning	 calculations,	 the																												
differences	 may	 indicate	 the	 uncertainties	 due	
to	the	digitization	of	 	positions	for	the	points	of												
interests	in	the	treatment	planning	system.		
	
	
ACKNOWLEDGMENT	
	
The	 Radiotherapy	 Department	 of	 Shahid																				
Beheshti	University	sponsored	the	purchase	of	the	
phantom	 materials	 and	 1ilms	 used	 in	 the																							
investigations.	The	authors	would	 like	to	present	
their	appreciation	 for	Dr	Mehdi	Ghorbani	 for	his	
invaluable	 contributions	 in	 this	 project.	 In																								
addition,	the	editorial	suggestions	by	Dr	Courtney	
Knaup	are	greatly	appreciated.		
	
Con(licts	of	interest:	none	to	declare.	
	
	
REFERENCES	
	
1. Gerbaulet A, PoFer R, Mazeron J,  Van Limbergen E,            
Editors (2002) The GEC ESTRO handbook of brachytherapy. 
Brussels: ESTRO [cited 2012 Feb1]. Available from :hFp://
estro-educaon.org/publicaons/Documents/GEC%
20ESTRO%20Handbook%20of%20Brachytherapy. html 
2. Mesbahi A (2008) Radial dose funcons of GZP6                        
intracavitary brachytherapy 60Co sources: treatment                    
planning system versus Monte Carlo calculaons.                          
Iran J Radiat Res, 5 (4): 181-6.  
3. Niroomand-Rad A, Blackwell CR, Coursey BM, Gall KP,                
Galvin JM, McLaughlin WL, Meigooni AS, Nath R, Rodgers J 
E, Soares CG (1998) Radiochromic film dosimetry:                
Recommendaons of AAPM Radiaon Therapy CommiFee 
Task Group 55. Med Phys, 25: 2093-116. 
4. Chiu-Tsao ST, Medich D, Munro J (2008) The
 
use of new 
GAFCHROMIC EBT film for 
125
I seed dosimetry in Solid                  
Water phantom. Med Phys, 35(8):  3787- 99.  
5.  Fragoso M, Love PA, Verhaegen F, Nalder C, Bidmead 
AM, Leach M, Webb S (2004) The dose distribuon of low 
dose rate Cs-137 in intracavitary brachyther-apy:                           
comparison of Monte Carlo simulaon, treatment planning 
calculaon and polymer gel measurement. Phys Med Biol, 
49(24): 5459–74. 
6.  Tod M, Meredith WJ (1953) Treatment of cancer of the 
cervix uteri—a revised Manchester method. Br J Radiol,         
26: 252–7. 
7. Internaonal Commission on   Units and Measurement 
(ICRU) Dose and Volume Specificaon for Reporng                          
Intracavitary   Therapy in Gynecology. ICRU Report 
No.38.1985; Bethesda (MD): ICRU. 
8.  ISP (Internaonal specialty products). Handling guide of 
GafChromic films .Available from: hFp://
online1.ispcorp.com/_layouts/Gafchromic/content/
products/ebt2/pdfs/
GAFCHROMICEBT2ScanHandlingGuide.pdf. 
9.  ImageJ Documentaon Wiki . Available from: hFp://
imagejdocu.tudor.lu/ 
10.Chan M, Zhang Q, Li J, Parhar P, Schupak K, Burman CH 
(2012) The Verificaon of iPlan commissioning by 
Radiochromic EBT2 Films. IJMPCERO, 1: 1-7. 
11.Sina S, Faghihi R, Meigooni AS,  Mehdizadeh S, Mosleh 
Shirazi MA, Zehtabian M (2011)  Impact of the vaginal 
applicator and dummy pellets on the dosimetry parameters 
of Cs-137 brachytherapy source. J Appl Clin Med Phys,                    
12(3): 183-93. 
12.Aldelaijan S, Mohammad H, Tomic N,  Liang L H, Deblois 
F, Sarfehnia A, Abdel-Rahman W, Seuntjens J, Devic S 
(2011) Radiochromic film dosimetry of HDR 
192
Ir source 
radiaon fields. Med Phys, 38(11): 6074-83. 
13. Lipińska J, Zwierzchowski G (2006) Dosimetric verificaon 
of the dose distribuon in pulsed dose rate brachytherapy. 
Rep Pract Oncol Radiother, 11: 223-8. 
14. Kohr P and Siebert A (2007) Quality assurance of                          
brachytherapy aCerloaders using a mul-slit phantom. 
Phys Med Biol, 52: N387–N91. 
Int. J. Radiat. Res., Vol. 14 No. 1, January 2016 71 
Gholami et al. / A novel phantom design for brachytherapy QA 
D
ow
nl
oa
de
d 
fro
m
 ijr
r.c
om
 at
 13
:05
 +0
33
0 o
n T
ue
sd
ay
 N
ov
em
be
r 1
2th
 20
19
    
    
  [ 
DO
I: 1
0.1
88
69
/ac
ad
pu
b.i
jrr.
14
.1.
67
 ]  
D
ow
nl
oa
de
d 
fro
m
 ijr
r.c
om
 at
 13
:05
 +0
33
0 o
n T
ue
sd
ay
 N
ov
em
be
r 1
2th
 20
19
    
    
  [ 
DO
I: 1
0.1
88
69
/ac
ad
pu
b.i
jrr.
14
.1.
67
 ]  
